$OMDA

Duffy Sean P. sold $327K of OMDA

Duffy Sean P. (Chief Executive Officer) sold 14,960 shares of Omada Health, Inc. (OMDA) at an average of $21.87 ($21.80–$22.59, $0.33M total) across 2 trades on 2026-09-10 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Duffy Sean P.
Published Sep 14, 2026, 9:13 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 14, 2026, 9:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$OMDA
Neutral
high confidence
Mentioned
$OMDA
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OMDANeutralLow
01

Why it matters

The disclosed sale is modest and unlikely to affect OMDA's share price, but it provides transparency for shareholders.

02

Market read

A routine insider sell with limited market impact; useful for compliance monitoring.

03

What to watch

Potential upcoming corporate actions or earnings that prompted the pre‑arranged sale.

Relevance 3/10Novelty 3/10Timing: sale reported Sep 14, covering a Sep 10 transaction

Background

Form 4 filings disclose insider transactions; a 10b5‑1 plan allows pre‑scheduled sales.

Company-level read

Ticker impact

$OMDANeutralHigh confidence
Context

CEO Sean Duffy sold 14,960 shares for $327K via a 10b5‑1 plan on Sep 10, 2026.

Expected impact

No significant price impact expected.

Evidence & confidence

The transaction size is small relative to market cap and follows a pre‑arranged plan, so it carries limited informational value.

Market effects

None; the sale is company‑specific and does not affect the digital health sector.

None; the filing is U.S.‑focused and does not influence broader regional markets.

Minimal; only relevant to investors tracking OMDA.

Counterpoint

The sell could be interpreted as a lack of confidence, but the 10b5‑1 plan suggests it is routine.

Key entities

  • Omada Health, Inc.

    Digital health platform listed on Nasdaq under ticker OMDA.

  • Sean P. Duffy

    Chief Executive Officer of Omada Health.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$OMDAHighAI 9/10

Omada Health (OMDA) Q2 2026 Earnings Call Transcript

Omada Health (OMDA) reported Q2 2026 revenue of $88 million, up 43% year over year, with GAAP gross margin of 73% and GAAP net income of $5 million. Adjusted EBITDA was $11 million. The company raised full-year revenue guidance to $334 million to $340 million and adjusted EBITDA to $21 million to $27 million, citing member growth and lower cost to serve.

$OMDAHigh

Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition

Omada Health, Inc. (OMDA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition • Revenue Grew 43% and Total Members Increased 45% Year over Year, with Gross Margin Reaching a New Quarterly Record • Company Announces Sean Duffy to Become Executive Chair and Wei-Li Shao to Become Ch